glp-1 medications lean muscle retention weight loss are producing real results. Most patients never see what's happening underneath the number on the scale. mass loss during aggressive caloric restriction isn't exclusive to GLP-1s — Gwyneth Paltrow, Andrew Huberman &

GLP-1 RAs are currently being explored for use in various new areas, such as cardiovascular disease, non-alcoholic steatohepatitis (NASH), Alzheimer's disease, and chronic kidney disease

Impact of 3-week citrulline supplementation on postprandial protein metabolism in malnourished older patients: the Ciproage randomized controlled trial

Facial volume loss from GLP-1 medications results from rapid weight reduction rather than direct drug effects on facial tissues, affecting fat compartments that provide structural support

Ongoing research into biomaterials and immune modulation aims to enhance the therapeutic efficacy of Gliadel wafers while minimizing these adverse effects, paving the way for more refined local intervention strategies that better modulate neuroinflammation in gliomas